Brain-derived neurotrophic factor V66M polymorphism in childhood-onset obsessive-compulsive disorder [2]

International Journal of Neuropsychopharmacology

Volumn 8, Issue 1, 2005, Pages 133-136

  Mössner, Rainald ^a   Walitza, Susanne ^a   Lesch, Klaus Peter ^a   Geller, Frank ^b   Barth, Nikolaus ^b   Remschmidt, Helmut ^b   Hahn, Freya ^c   Herpertz Dahlmann, Beate ^c   Fleischhaker, Christian ^d   Schulz, Eberhard ^d   Warnke, Andreas ^a   Hinney, Anke ^b   Wewetzer, Christoph ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c RWTH AACHEN UNIVERSITY   (Germany)

^d UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR;

ADOLESCENT; ALLELE; BDNF GENE; CELL PROLIFERATION; CELL SURVIVAL; DNA POLYMORPHISM; FEMALE; GENE; GENOTYPE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; NERVE CELL; OBSESSIVE COMPULSIVE DISORDER; ONSET AGE; PRIORITY JOURNAL; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; SCHOOL CHILD;

ADOLESCENT; ADULT; ALLELES; AMINO ACID SUBSTITUTION; ANXIETY DISORDERS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BRAIN-DERIVED NEUROTROPHIC FACTOR; CHILD; COMORBIDITY; DEPRESSIVE DISORDER; FEMALE; GENOTYPE; HETEROZYGOTE DETECTION; HIPPOCAMPUS; HUMANS; MALE; METHIONINE; OBSESSIVE-COMPULSIVE DISORDER; POLYMORPHISM, GENETIC; RISK FACTORS; VALINE;

EID: 20144363433     PISSN: 14611457     EISSN: None     Source Type: Journal    
DOI: 10.1017/S146114570400495X     Document Type: Letter

References (17)

1. APA (2000). DSM-IV: Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Association.
2. Cargill M, Altshuler D, Ireland J, Sklar P, Ardlie K, Patil N, Shaw N, Lane CR, Lim EP, Kalyanaraman N, Nemesh J, Ziaugra L, Friedland L, Rolfe A, Warrington J, Lipshutz R, Daley GQ, Lander ES (1999). Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nature Genetics 22, 231-238.
3. Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, Zaitsev E, Gold B, Goldman D, Dean M, Lu B, Weinberger DR (2003). The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112, 257-269.
4. Flament MF, Koby E, Rapoport JL, Berg CJ, Zahn T, Cox C, Denckla M, Lenane M (1990). Childhood obsessive-compulsive disorder: a prospective follow-up study. Journal of Child Psychology and Psychiatry 31, 363-380.
5. Geller DA, Biederman J, Faraone SV, Bellordre CA, Kim GS, Hagermoser L, Cradock K, Frazier J, Coffey BJ (2001). Disentangling chronological age from age of onset in children and adolescents with obsessive-compulsive disorder. International Journal of Neuropsychopharmacology 4, 169-178.
6. Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR, Charney DS (1989). The Yale-Brown Obsessive Compulsive Scale. II. Validity. Archives of General Psychiatry 46, 1012-1016.
7. Hall D, Dhilla A, Charalambous A, Gogos JA, Karayiorgou M (2003). Sequence variants of the brain-derived neurotrophic factor (BDNF) gene are strongly associated with obsessive-compulsive disorder. American Journal of Human Genetics 73, 370-376.
8. Hanna GL, Yuwiler A, Coates JK (1995). Whole blood serotonin and disruptive behaviors in juvenile obsessive-compulsive disorder. Journal of the American Academy of Child and Adolescent Psychiatry 34, 28-35.
9. Hariri AR, Goldberg TE, Mattay VS, Kolachana BS, Callicott JH, Egan MF, Weinberger DR (2003). Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. Journal of Neuroscience 23, 6690-6694.
10. Mamounas LA, Blue ME, Siuciak JA, Altar CA (1995). Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain. Journal of Neuroscience 15, 7929-7939.
11. Mössner R, Daniel S, Albert D, Heils A, Okladnova O, Schmitt A, Lesch KP (2000). Serotonin transporter function is modulated by brain-derived neurotrophic factor (BDNF) but not nerve growth factor (NGF). Neurochemistry International 36, 197-202.
12. Pauls DL, Alsobrook 2nd JP, Goodman W, Rasmussen S, Leckman JF (1995). A family study of obsessive-compulsive disorder. American Journal of Psychiatry 152, 76-84.
13. Seidah NG, Benjannet S, Pareek S, Chretien M, Murphy RA (1996). Cellular processing of the neurotrophin precursors of NT3 and BDNF by the mammalian proprotein convertases. FEBS Letters 379, 247-250.
14. Sen S, Nesse RM, Stoltenberg SF, Li S, Gleiberman L, Chakravarti A, Weder AB, Burmeister M (2003). A BDNF coding variant is associated with the NEO personality inventory domain neuroticism, a risk factor for depression. Neuropsychopharmacology 28, 397-401.
15. Spielman RS, McGinnis RE, Ewens WJ (1993). Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). American Journal of Human Genetics 52, 506-516.
16. Unnewehr S (1995). Diagnosis of psychiatric disorders in children and adolescents using structured interviews [in German]. Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie 23, 121-132.
17. Zohar J, Chopra M, Sasson Y, Amiaz R, Amital D (2000). Obsessive compulsive disorder: serotonin and beyond. World Journal of Biological Psychiatry 1, 92-100.